Navigation Links
Is RNA Amplification Necessary for Microarrays?


RNA amplification using the Van Gelder and Eberwine technique (1) has been used extensively for target synthesis and labeling in array analysis experiments. Amplification of RNA is clearly necessary when working with limited samples (needle biopsies, LCM samples, etc.), but is it necessary when the availability of sample is not limiting? Is there additional biologically relevant information that can be obtained from array analysis using amplified RNA as a target? In this article we provide a brief synopsis of the findings of Polacek et al. (2) and Feldman et al. (3) on why amplified RNA (aRNA) might be a better choice than unamplified RNA for microarrays.


The Polacek Experiments
Polacek's group tested the fidelity of differential gene expression data using amplified RNA in a well established in vitro model of cytokine [tumor necrosis factor (TNF-α)]-stimulated human aortic endothelial cells (HAEC). 100 ng of total RNA, isolated from HAECs using a glass filter based kit, was amplified using Ambion's MessageAmp aRNA Kit, producing 4-5 g of aRNA (cRNA). 2 g of this aRNA was labeled with 33P by reverse transcription using hexanucleotide random primers; 10 g of Total RNA (unamplified) was labeled with 33P by reverse transcription using Oligo d(T)15 primers. These targets were hybridized to arrays containing 13,284 human cDNA elements.

Analysis of differential gene expression in the cells treated with TNF-α compared to untreated control cells identified 1296 genes in the amplified samples and 155 genes in the unamplified samples whose expression was affected by cytokine treatment. By comparing genes identified with probe prepared by both amplified and unamplified RNA, three categories were created: "genes common in amplified and unamplified RNA", "genes unique to amplified RNA", and "genes unique to unamplified RNA" (Figure 1). Real-time quantitative RT-PCR (qRT-PCR) analysis using SYBR Green detection of expression differences of a subset of the genes from each category was carried out. A summary of the observed results from qRT-PCR analysis and array analysis is shown in Table 1. The following conclusions were drawn from these validation studies:

(A) Because genes were identified as having differential expression with both preparations of labeled target, "common identified genes" are considered to have the highest probability of being verifiably regulated by TNF-α. In general, the ratio of gene expression with and without TNF-α treatment from amplified RNA had a closer correlation with the qRT-PCR data than ratios from unamplified RNA. 94% of the "common identified genes" show similar kinase-regulation patterns between amplified and unamplified samples.

(B) "Genes unique to amplified RNA" were ranked by P-values, and 24 genes (2.1% of the total 1,150) were selected from the entire range of P-values for validation by qRT-PCR. Similar regulation patterns between array and qRT-PCR analysis were observed in 16 of the 24 genes tested.

(C) Six from the category of "genes unique to unamplified RNA" were validated by qRT-PCR. Of these, three genes showed a similar expression ratio by qRT-PCR analysis.

Thus amplification improved the sensitivity of the array analysis, enabling the identification of biologically regulated genes that might have been missed if unamplified RNA had been used.

Figure 1. Venn Diagrams Showing the Differential Distribution of Genes Expressed With and Without TNF-α Treatment. Of the total 13,284 genes tested, 1,296 were identified from amplified RNA vs. 146 genes that are commonly represented in both samples.

Table 1. Microarray Results. This study involved the comparison of multiple replicate arrays for each condition tested: (+TNF-α and TNF-α) with use of four unamplified and five amplified RNA samples. The gene expression ratios between microarray and quantitative RT-PCR data is presented in this table.


The Feldman Experiments
Feldman et al. evaluated the fidelity of microarrays probed with amplified vs. total RNA by comparing microarray data with real-time qRT-PCR. They compared gene expression in two murine tumor cell lines (B16F10 and MC38) using mouse microarrays containing 2601 elements. In their experiments, all array hybridizations were repeated using reciprocal fluorescence to minimize the effects of labeling bias (i.e. each array was hybridized with with Cy3 labeled B16F10 RNA and Cy5 labeled MC38 RNA, and then a second identical array was hybridized with Cy5 labeled B16F10 RNA and Cy3 labeled MC38 RNA).

The following differences were observed between total RNA and amplified RNA samples:

(A) Correlation coefficients between reciprocal arrays were consistently higher with probes generated by a single or two rounds of amplification than with probes from unamplified RNA.

(B) Total RNA samples showed a higher correlation between duplicate forward or reciprocal arrays than between forward and reciprocal arrays. This was probably partially due to labeling bias. Total RNA also showed increased variability between duplicate arrays compared to amplified RNA. The authors speculate that data generated with total RNA (unamplified) may be more subject to the effects of background on the low-copy number transcripts than amplified RNA.

(C) The correlation between arrays using total RNA and amplified RNA was found to be similar to duplicate arrays probed with total RNA. This observation corroborates the finding that amplification does not significantly bias the gene expression data.

The authors further evaluated whether the individual genes that were differentially expressed in amplified samples would have been identified as such using total RNA. For this experiment, the number of "outliers" defined by authors as "A gene with expression ratios of greater than or equal to 2.0 or less than or equal to 0.5 in two reciprocal microarray analysis" identified using total RNA or amplified RNA (one or two rounds of amplification) were compared. The amplified samples identified approximately 80% of the genes selected as outliers with total RNA, with an 80% concordance between target made by one and two rounds of amplification. Thus amplification yielded approximately 2 times more outliers than total RNA, with 80% of these showing similar trends in expression between amplified and total RNA samples. Validation of the "outliers" between total RNA and amplified RNA was carried out using real-time PCR analysis. The PCR data suggested that the majority of outliers identified using amplified RNA are valid. Thus Feldman et al. also conclude that all RNA samples should undergo at least one round of amplification to maximize the quality of array data for detection of differentially expressed genes.

SYBR Green is a registered trademark of Molecular Probes, Inc.
Cy is a trademark of Amersham Biosciences.


back to top


Ordering Information
Cat# Product Name Size 1750 MessageAmp aRNA Kit 20 rxns 1751 MessageAmp II aRNA Amplification Kit 20 rxns
'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
2. Simple Purification of DNA from Plasmid Minipreps, PCR Amplifications and Agarose Gels
3. Greater Amplification Specificity with New Hot Start PCR Enzyme
4. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
5. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
6. Improve Amplification Specificity with Hot Start PCR Enzyme
7. Amplification of the amoA Gene of Nitrosococcus oceani Bacteria Using Eppendorf MasterTaq
8. Amplification of Mouse cDNAs for Microarrays Using the Eppendorf MasterTaq Kit
9. Optimizing the Direct Amplification of Missing cDNA 5 Ends Using the Eppendorf Mastercycler gradient
10. Optimizing DNA Amplification Protocols using the Eppendorf Mastercycler
11. Amplification of Epstein-Barr Virus Exon C with Difficult Primers Using Eppendorf Mastercycler gradient
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: RNA Amplification Necessary for Microarrays

(Date:12/24/2014)... LOUIS , Dec. 23, 2014 ... today that the waiting period under the Hart-Scott-Rodino ... the acquisition expired on December 22, 2014, thereby ... review requirement for the acquisition of the Company ... U.S. antitrust clearance satisfies another condition to closing ...
(Date:12/22/2014)... Brussels (PRWEB) December 22, 2014 The ... the global leader of technical training across the life ... Clinical Data Management (SCDM) to provide the organization's ... certification programs —providing access to the more than 350 ... SCDM members with 10% off when registering for a ...
(Date:12/22/2014)... , Dec. 22, 2014  Alternative Energy ... that it has signed a letter of intent ... has developed and patented a nanotechnology-based development platform ... products that enable rapid on-site collection and testing ... and health issues in an immediate, non-invasive and ...
(Date:12/22/2014)... The American Journal of ... research, reviews and editorials addressing developments and pathways ... published a provocative article exploring the role of ... potential treatment of prostate cancer. , The ... the possibility that there could be a connection ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3CfPIE Announces Partnership with the Society for Clinical Data Management 2CfPIE Announces Partnership with the Society for Clinical Data Management 3ALNE Announces Intention To Acquire BioTechPharma 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 2Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 3Prostate Cancer Experts Dissect the Role of Follicle-stimulating Hormone in the Development, Progression and Potential Treatment of Prostate Cancer 4
... Inc., a division of GE Industrial Systems, announced ... a Green Bay manufacturing software development company. , ... Execution Systems (MES) technology for the manufacturing of ... as well as for pulp and paper products. ...
... to fighting breast cancer, and GE Medical Systems, headquartered ... AD and Second Look Digital are computer-aided detection (CAD) ... digital mammography system. CADx Systems, Inc. developed the Second ... the review of breast exams. , ,GE is ...
... until he gets to the better drugs, faster part of ... behind the Madison-based companys products is likely to hit the ... age when diseases and treatments become as common in conversation ... and a half-year-old company that Vodenlich joined as president earlier ...
Cached Biology Technology:Green Bay Software Company Purchased by GE 2New Technology in Fight against Breast Cancer 2Chipping Away at Drug Development 2Chipping Away at Drug Development 3
(Date:12/19/2014)... Dec. 18, 2014  23andMe, Inc., the leading personal ... that pinpoints fine-scale differences in genetic ancestry of individuals ... Since immigrants first arrived more than four ... has served as a meeting place for peoples ... and the ongoing mixing of peoples with African, European, ...
(Date:12/17/2014)... 2014 Research and Markets ( ... "Samsung Galaxy S5 - Home Button Synaptics ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... technology than the iPhone 5S, Samsung introduces for ... product. The Galaxy S5 home button ...
(Date:12/17/2014)... YORK , Dec. 15, 2014  HITLAB ... Good Clinical Practices (GCP) audit to confirm its ... (FDA) regulations. This accomplishment enables HITLAB to conduct ... utilizing the highest principles for patient safety and ... improve global healthcare access, quality, and delivery with ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2
... the U.S. Department of Energy,s Brookhaven National Laboratory have ... against human adenovirus, a cause of ailments ranging from ... published in FEBS Letters , a journal of ... researchers sifted through thousands of compounds to determine which ...
... from Uppsala University, Sweden, show that the key to ... and Creutzfeldt-Jakob disease may lie in the ribosome, the ... recently published in the Journal of Biological Chemistry ... by misfolding of prion proteins. Examples of prion diseases ...
... that has sickened thousands in Haiti came from a single ... the past three years as some have thought, according to ... open-access journal of the American Society for Microbiology. ... findings that indicate Vibrio cholerae bacteria were introduced ...
Cached Biology News:Scientists identify promising antiviral compounds 2Scientists identify promising antiviral compounds 3The ribosome -- a new target for antiprion medicines 2Genomes of cholera bacteria from Haiti confirm epidemic originated from single source 2Genomes of cholera bacteria from Haiti confirm epidemic originated from single source 3
MAGP-2 (C-19)...
Laminin gamma-2 (G-16)...
... Proliferation Kit, For 100 slides. Immunocytochemistry.Sample ... in vitro tissue labeling.Recommended cell number: ... (labeling 1-2 hours).Store at 2-8 C ... Category: Drug Screening & Cellular Assays, ...
Dysadherin 2 (L-15)...
Biology Products: